2 publications

• Published Subscription 12 Feb 2024

  Rivaroxaban: A Comprehensive Review of an Anticoagulant Revolution

  By Dr. Himanshu Solanki, Nimisha Vala, Shruti Adhikari, Neha Patil, Jaydatta Dhakane, Ajinkya Thakare

  Abstract: Rivaroxaban, a prominent direct oral anticoagulant (DOAC), has garnered attention for its pivotal role in preventing and treating thromboembolic diseases. Its introduction into clinical practice has marked a significant advancement in anticoagulant therapy. The mechanism of action of rivaroxaban involves selective inhibition of factor Xa, a crucial component in the coagulation cascade. This targeted approach distinguishes it from traditional anticoagulant and contributes to its efficacy. The significance of rivaroxaban lies …

  Published in Research & Reviews: A Journal of Drug Design & Discovery · Vol. 10, Issue 3, 2023 · pp. 17–23 Read article →

• Published Subscription 23 May 2023

  Ferrous bisglycinate (FBG) as a source of iron supplement

  By Himanshu Solanki, Naazneen Siddique, Priyanka Shah, Nimisha Vala

  Abstract: Iron is a crucial element that holds significance in various essential biological functions. These include the synthesis of heme, which constitutes the core component of hemoglobin, the protein responsible for transporting oxygen in the bloodstream. Additionally, iron is involved in the production of myoglobin, energy metabolism, neurotransmitter synthesis, collagen formation, and the functioning of the immune system. There are mainly two reasons for iron imbalance: Iron deficiency and Iron overload. …

  Published in Research and Reviews: A Journal of Pharmacology · Vol. 13, Issue 1, 2023 · pp. 32–41 Read article →